To say that Khloé Kardashian has had an eventful past couple of years would be putting it lightly. Just last week she and Lamar Odom finalized their divorce, Caitlyn Jenner made her…
Ten seasons in and The Real Housewives of Orange County may be giving viewers the realest season yet. Already this year the Bravo reality show has captured a birth, a death and chronicled a…
“The tremendous amount of support I’ve gotten has been overwhelming,” Caitlyn Jenner admitted on the series premiere of I Am Cait. And she isn’t kidding. Not only…
“The tremendous amount of support I’ve gotten has been overwhelming,” Caitlyn Jenner admitted on the series premiere of I Am Cait. And she isn’t kidding. Not only…
By Tova Cohen and Steven Scheer TEL AVIV (Reuters) – Teva Pharmaceutical Industries has agreed to buy Allergan Plc’s generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world’s largest pharmaceutical firms. The deal, the largest in Israel’s corporate history, prompted Teva to drop its $40 billion hostile bid for Mylan, which used a poison pill-style defense
Bellerophon Therapeutics Inc’s shares plummeted more than 60 percent on Monday after the company said an injectable heart drug it is developing under license failed in a study. The drug, bioabsorbable cardiac matrix, was licensed from BioLineRx Ltd in 2009 after animal studies showed that it acted as a “scaffold” to support the heart wall and was likely to prevent further structural damage. When BCM is administered after a heart